プログラム委員会
-
Masayoshi Higuchi Head of Quality & Regulatory Compliance Unit,
Chugai Pharmaceutical Co., Ltd., Japan -
Akiko Ikeda, RPH PRIMO, External Researcher/Consultant
National Cancer Center, Japan -
Yumi Inukai New Drug Regulatory Affairs Dept.
Daiichi Sankyo Co., Ltd., Japan -
Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
Pfizer R&D Japan G.K., Japan -
Yomei Matsuoka, MSC, RPH Vice President, Pharmacoepidemiology and PMS Department
Daiichi Sankyo Co., Ltd., Japan -
Miwa Tamada Manager, New Drug RA Department, Regulatory Affairs
GlaxoSmithKline K.K., Japan